...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The FASEB Journal >Inorganic arsenic promotes luminal to basal transition and metastasis of breast cancer
【24h】

Inorganic arsenic promotes luminal to basal transition and metastasis of breast cancer

机译：Inorganic arsenic promotes luminal to basal transition and metastasis of breast cancer

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Abstract Inorganic arsenic (iAs/As2O32?) is an environmental toxicant found in watersheds around the world including in densely populated areas. iAs is a class I carcinogen known to target the skin, lungs, bladder, and digestive organs, but its role as a primary breast carcinogen remains controversial. Here, we examined a different possibility: that exposure to iAs promotes the transition of well‐differentiated epithelial breast cancer cells characterized by estrogen and progesterone receptor expression (ER+/PR+), to more basal phenotypes characterized by active proliferation, and propensity to metastasis in vivo. Our results indicate two clear phenotypic responses to low‐level iAs that depend on the duration of the exposure. Short‐term pulses of iAs activate ER signaling, consistent with its reported pseudo‐estrogen activity, but longer‐term, chronic treatments for over 6?months suppresses both ER and PR expression and signaling. In fact, washout of these chronically exposed cells for up to 1?month failed to fully reverse the transcriptional and phenotypic effects of prolonged treatments, indicating durable changes in cellular physiologic identity. RNA‐seq studies found that chronic iAs drives the transition toward more basal phenotypes characterized by impaired hormone receptor signaling despite the conservation of estrogen receptor expression. Because treatments for breast cancer patients are largely designed based on the detection of hormone receptor expression, our results suggest greater scrutiny of ER+ cancers in patients exposed to iAs, because these tumors may spawn more aggressive phenotypes than unexposed ER+ tumors, in particular, basal subtypes that tend to develop therapy resistance and metastasis.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号